Inventor
POWER CHRISTINE
FR23 patents
⚠️ This page may combine multiple inventors who share the name “POWER CHRISTINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARES TRADING SA
8 patentsUS7622555B2Nov 24, 2009
Cytokine antagonist molecules
ARES TRADING SA56 citations94
US7619065B2Nov 17, 2009
Cystine-knot fold protein
ARES TRADING SA3 citations57
US7700724B2Apr 20, 2010
Isolated INSP 163 protein
ARES TRADING SA2 citations55
US9534054B2Jan 3, 2017
Monoclonal antibody directed against CXCR5
ARES TRADING SA0 citations50
US7803383B2Sep 28, 2010
Method of treatment comprising administration of a cytokine antagonist molecule
ARES TRADING SA0 citations48
US7557079B2Jul 7, 2009
Metalloprotease proteins
ARES TRADING SA0 citations47
US7514533B2Apr 7, 2009
TNF-like secreted protein
ARES TRADING SA1 citations46
US7341851B2Mar 11, 2008
IL-8 like protein
ARES TRADING SA0 citations44
MERCK SERONO SA
6 patentsUS7670802B2Mar 2, 2010
CXC-chemokine antagonists isolated from Rhipicephalus sanguineus
MERCK SERONO SA0 citations50
US7655628B2Feb 2, 2010
Method for treating liver cirrhosis or interstitial pulmonary fibrosis
MERCK SERONO SA1 citations49
US7635576B2Dec 22, 2009
CC-chemokine binding tick proteins
MERCK SERONO SA0 citations48
US7803910B2Sep 28, 2010
Soluble CD164 polypeptides
MERCK SERONO SA0 citations44
US7611867B2Nov 3, 2009
CC-chemokine binding tick proteins
MERCK SERONO SA0 citations44
US7585840B2Sep 8, 2009
Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
MERCK SERONO SA0 citations39
SERONO LAB
3 patentsUS7638480B2Dec 29, 2009
Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
SERONO LAB10 citations82
US7393660B2Jul 1, 2008
CC-chemokine binding tick proteins
SERONO LAB2 citations59
US7341995B2Mar 11, 2008
Use of SARP-1 for the treatment and/or prevention of scleroderma
SERONO LAB2 citations59